Elimination of OX8+ cells prolongs cardiac but not pancreatic allograft survival across minor (non-MHC) histocompatibility barriers.
Roza
A M
AM
Department of Transplant Surgery, Medical College of Wisconsin, Milwaukee.
Johnson
C P
CP
Adams
M B
MB
Naji
A
A
D000818:Animals; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D003921:Diabetes Mellitus, Experimental / Q000276:immunology / Q000601:surgery*; D006085:Graft Survival; D016027:Heart Transplantation / Q000276:immunology*; D008297:Male; D015778:Minor Histocompatibility Antigens; D016035:Pancreas Transplantation / Q000276:immunology*; D051381:Rats; D011917:Rats, Inbred Lew; D011920:Rats, Inbred WF; D013601:T-Lymphocytes / Q000166:cytology / Q000276:immunology*; D014184:Transplantation, Homologous
D000911:Antibodies, Monoclonal; D015778:Minor Histocompatibility Antigens